NCT05267626 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05267626
Title	Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Ralpha Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Recruitment	Recruiting
Gender	both
Phase	Phase Ib/II
Variant Requirements	Yes
Sponsors	Aulos Bioscience, Inc.
Indications	skin melanoma Advanced Solid Tumor lung non-small cell carcinoma
Therapies	Aldesleukin + AU-007 + Nivolumab Aldesleukin + AU-007 + Avelumab Aldesleukin + AU-007 AU-007
Age Groups:	adult \| senior
Covered Countries	USA \| AUS

NCT05267626
Clinical Trial Detail